Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 86

1.

Impaired 11β-Hydroxysteroid Dehydrogenase Type 2 in Glucocorticoid-Resistant Patients.

Vitellius G, Delemer B, Caron P, Chabre O, Bouligand J, Pussard E, Trabado S, Lombes M.

J Clin Endocrinol Metab. 2019 Nov 1;104(11):5205-5216. doi: 10.1210/jc.2019-00800.

PMID:
31225872
2.

Potentiation of mitotane action by rosuvastatin: New insights for adrenocortical carcinoma management.

Boulate G, Amazit L, Naman A, Seck A, Paci A, Lombes A, Pussard E, Baudin E, Lombes M, Hescot S.

Int J Oncol. 2019 Jun;54(6):2149-2156. doi: 10.3892/ijo.2019.4770. Epub 2019 Apr 3.

PMID:
30942448
3.

Corticosteroid receptors adopt distinct cyclical transcriptional signatures.

Le Billan F, Amazit L, Bleakley K, Xue QY, Pussard E, Lhadj C, Kolkhof P, Viengchareun S, Fagart J, Lombès M.

FASEB J. 2018 Oct;32(10):5626-5639. doi: 10.1096/fj.201800391RR. Epub 2018 May 7.

PMID:
29733691
4.

Comparative profiling of adrenal steroids in maternal and umbilical cord blood.

Travers S, Martinerie L, Boileau P, Xue QY, Lombès M, Pussard E.

J Steroid Biochem Mol Biol. 2018 Apr;178:127-134. doi: 10.1016/j.jsbmb.2017.11.012. Epub 2017 Nov 28.

PMID:
29191401
5.

Alterations of adrenal steroidomic profiles in preterm infants at birth.

Travers S, Martinerie L, Boileau P, Lombès M, Pussard E.

Arch Dis Child Fetal Neonatal Ed. 2018 Mar;103(2):F143-F151. doi: 10.1136/archdischild-2016-312457. Epub 2017 Jul 26.

PMID:
28747362
6.

Mid-regional pro-adrenomedullin (MR-proADM), a marker of positive fluid balance in critically ill patients: results of the ENVOL study.

Vigué B, Leblanc PE, Moati F, Pussard E, Foufa H, Rodrigues A, Figueiredo S, Harrois A, Mazoit JX, Rafi H, Duranteau J.

Crit Care. 2016 Nov 9;20(1):363.

7.

Multiplexed steroid profiling of gluco- and mineralocorticoids pathways using a liquid chromatography tandem mass spectrometry method.

Travers S, Martinerie L, Bouvattier C, Boileau P, Lombès M, Pussard E.

J Steroid Biochem Mol Biol. 2017 Jan;165(Pt B):202-211. doi: 10.1016/j.jsbmb.2016.06.005. Epub 2016 Jun 23.

PMID:
27339652
8.

High Mortality Risk in Hypoglycemic and Dysglycemic Children Admitted at a Referral Hospital in a Non Malaria Tropical Setting of a Low Income Country.

Barennes H, Sayavong E, Pussard E.

PLoS One. 2016 Feb 24;11(2):e0150076. doi: 10.1371/journal.pone.0150076. eCollection 2016.

9.

Aldosterone-Signaling Defect Exacerbates Sodium Wasting in Very Preterm Neonates: The Premaldo Study.

Martinerie L, Pussard E, Yousef N, Cosson C, Lema I, Husseini K, Mur S, Lombès M, Boileau P.

J Clin Endocrinol Metab. 2015 Nov;100(11):4074-81. doi: 10.1210/jc.2015-2272. Epub 2015 Sep 8.

PMID:
26348350
10.

Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study.

Franc S, Daoudi A, Pochat A, Petit MH, Randazzo C, Petit C, Duclos M, Penfornis A, Pussard E, Not D, Heyman E, Koukoui F, Simon C, Charpentier G.

Diabetes Obes Metab. 2015 Dec;17(12):1150-7. doi: 10.1111/dom.12552. Epub 2015 Oct 8.

11.

Improving the management of dysglycemia in children in the developing world.

Barennes H, Pussard E.

Am J Trop Med Hyg. 2015 Jan;92(1):6-8. doi: 10.4269/ajtmh.14-0212. Epub 2014 Oct 13.

12.

Sublingual sugar for infant hypoglycaemia.

Barennes H, Willcox ML, Graz B, Pussard E.

Lancet. 2014 Apr 5;383(9924):1208. doi: 10.1016/S0140-6736(14)60601-2. No abstract available.

PMID:
24703563
13.

Radioimmunoassay of free plasma metanephrines for the diagnosis of catecholamine-producing tumors.

Pussard E, Chaouch A, Said T.

Clin Chem Lab Med. 2014 Mar;52(3):437-44. doi: 10.1515/cclm-2013-0406.

PMID:
24088613
14.

Childhood dysglycemia: prevalence and outcome in a referral hospital.

Sambany E, Pussard E, Rajaonarivo C, Raobijaona H, Barennes H.

PLoS One. 2013 May 31;8(5):e65193. doi: 10.1371/journal.pone.0065193. Print 2013.

15.

Changes in urine composition after trauma facilitate bacterial growth.

Aubron C, Huet O, Ricome S, Borderie D, Pussard E, Leblanc PE, Bouvet O, Vicaut E, Denamur E, Duranteau J.

BMC Infect Dis. 2012 Nov 29;12:330. doi: 10.1186/1471-2334-12-330.

16.

Lack of renal 11 beta-hydroxysteroid dehydrogenase type 2 at birth, a targeted temporal window for neonatal glucocorticoid action in human and mice.

Martinerie L, Pussard E, Meduri G, Delezoide AL, Boileau P, Lombès M.

PLoS One. 2012;7(2):e31949. doi: 10.1371/journal.pone.0031949. Epub 2012 Feb 16.

17.

Community management of anti-malarials in Africa and iatrogenic risk.

Orostegui L, Balu L, Chevret L, Habes D, Pussard E.

J Trop Pediatr. 2011 Jun;57(3):225-6. doi: 10.1093/tropej/fmq074. Epub 2010 Aug 31.

PMID:
20807830
18.

Is it too soon to eliminate quinine?

Barennes H, Srour LM, Pussard E.

Lancet Infect Dis. 2010 Mar;10(3):141-2. doi: 10.1016/S1473-3099(10)70009-8. No abstract available.

PMID:
20185089
19.

Physiological partial aldosterone resistance in human newborns.

Martinerie L, Pussard E, Foix-L'Hélias L, Petit F, Cosson C, Boileau P, Lombès M.

Pediatr Res. 2009 Sep;66(3):323-8. doi: 10.1203/PDR.0b013e3181b1bbec.

20.

Reference intervals for urinary catecholamines and metabolites from birth to adulthood.

Pussard E, Neveux M, Guigueno N.

Clin Biochem. 2009 Apr;42(6):536-9. doi: 10.1016/j.clinbiochem.2008.10.022. Epub 2008 Nov 11.

PMID:
19027729
21.

Increased uptake of quinine into the brain by inhibition of P-glycoprotein.

Pussard E, Merzouk M, Barennes H.

Eur J Pharm Sci. 2007 Oct;32(2):123-7. Epub 2007 Jul 10.

PMID:
17698330
22.

Quinine distribution in pregnant mice with Plasmodium berghei malaria.

Lirussi F, Pussard E.

Eur J Pharm Sci. 2006 Jul;28(4):284-90. Epub 2006 Mar 22.

PMID:
16716571
23.
24.

Sublingual sugar administration as an alternative to intravenous dextrose administration to correct hypoglycemia among children in the tropics.

Barennes H, Valea I, Nagot N, Van de Perre P, Pussard E.

Pediatrics. 2005 Nov;116(5):e648-53.

PMID:
16263979
25.

Dose-dependent resorption of quinine after intrarectal administration to children with moderate Plasmodium falciparum malaria.

Pussard E, Straczek C, Kaboré I, Bicaba A, Balima-Koussoube T, Bouree P, Barennes H.

Antimicrob Agents Chemother. 2004 Nov;48(11):4422-6.

26.

Quinine distribution in mice with Plasmodium berghei malaria.

Pussard E, Bernier A, Fouquet E, Bouree P.

Eur J Drug Metab Pharmacokinet. 2003 Jan-Mar;28(1):11-20.

PMID:
14503660
27.

Intrarectal pharmacokinetics of two formulations of quinine in children with falciparum malaria.

Barennes H, Sterlingot H, Nagot N, Meda H, Kaboré M, Sanou M, Nacro B, Bourée P, Pussard E.

Eur J Clin Pharmacol. 2003 Feb;58(10):649-52. Epub 2003 Jan 29.

PMID:
12610739
28.

[Intrarectal administration of quinine: an early treatment for severe malaria in children?].

Barennes H, Kailou D, Pussard E, Munjakazi JM, Fernan M, Sherouat H, Sanda A, Clavier F, Verdier F.

Sante. 2001 Jul-Sep;11(3):145-53. French.

29.

Haemodynamic responses to a ring-deleted analogue of atrial natriuretic peptide in rats with cirrhosis.

Moreau R, Tazi KA, Komeichi H, Pussard E, Lebrec D.

Liver. 2000 Feb;20(1):88-92.

PMID:
10726965
30.
31.

Quinine disposition in globally malnourished children with cerebral malaria.

Pussard E, Barennes H, Daouda H, Clavier F, Sani AM, Osse M, Granic G, Verdier F.

Clin Pharmacol Ther. 1999 May;65(5):500-10.

PMID:
10340915
32.

An open randomized clinical study of intrarectal versus infused Quinimax for the treatment of childhood cerebral malaria in Niger.

Barennes H, Munjakazi J, Verdier F, Clavier F, Pussard E.

Trans R Soc Trop Med Hyg. 1998 Jul-Aug;92(4):437-40.

PMID:
9850403
33.

Plasma concentrations of cyclic 3', 5'-guanosine monophosphate in patients with cirrhosis: relationship with atrial natriuretic peptide and haemodynamics.

Kirstetter P, Moreau R, Vachiery F, Gadano A, Soupison T, Pilette C, Pussard E, Cailmail S, Takahashi H, Lebrec D.

J Gastroenterol Hepatol. 1997 Mar;12(3):233-6.

PMID:
9142641
34.

Haemodynamic and hormonal responses to long-term inhibition of nitric oxide synthesis in rats with portal hypertension.

Pilette C, Moreau R, Sogni P, Kirstetter P, Cailmail S, Pussard E, Lebrec D.

Eur J Pharmacol. 1996 Sep 19;312(1):63-8.

PMID:
8891579
35.

Placebo-controlled, randomized, double-blind study of intravenous enalaprilat efficacy and safety in acute cardiogenic pulmonary edema.

Annane D, Bellissant E, Pussard E, Asmar R, Lacombe F, Lanata E, Madonna O, Safar M, Giudicelli JF, Gajdos P.

Circulation. 1996 Sep 15;94(6):1316-24.

PMID:
8822986
36.

Validation of HPLC-amperometric detection to measure serotonin in plasma, platelets, whole blood, and urine.

Pussard E, Guigueno N, Adam O, Giudicelli JF.

Clin Chem. 1996 Jul;42(7):1086-91.

37.

Efficacy and pharmacokinetics of a new intrarectal quinine formulation in children with Plasmodium falciparum malaria.

Barennes H, Pussard E, Mahaman Sani A, Clavier F, Kahiatani F, Granic G, Henzel D, Ravinet L, Verdier F.

Br J Clin Pharmacol. 1996 May;41(5):389-95.

38.

Systemic, pulmonary, brachial, renal and hepato-splanchnic hemodynamic effects of spirapril in severe congestive heart failure.

Bellissant E, Annane D, Pussard E, Thuillez C, Giudicelli JF.

Fundam Clin Pharmacol. 1996;10(2):127-35.

PMID:
8737955
40.

Intrarectal Quinimax (an association of Cinchona alkaloids) for the treatment of Plasmodium falciparum malaria in children in Niger: efficacy and pharmacokinetics.

Barennes H, Kahiatani F, Pussard E, Clavier F, Meynard D, Njifountawouo S, Verdier F.

Trans R Soc Trop Med Hyg. 1995 Jul-Aug;89(4):418-21.

PMID:
7570885
41.

[Role of modulators in Plasmodium falciparum resistance to antimalarials].

Verdier F, Pussard E.

Med Trop (Mars). 1995;55(4 Suppl):27-32. Review. French.

PMID:
8649262
42.

Role of the renin-angiotensin system in systemic and regional vascular responses to orthostatic stress in healthy volunteers.

Duranteau J, Pussard E, Berdeaux A, Giudicelli JF.

Fundam Clin Pharmacol. 1995;9(5):479-87.

PMID:
8617412
43.

Pharmacokinetics and metabolism of amopyroquin after administration of two doses of 6 mg/kg im 24 h apart to healthy volunteers.

Pussard E, Chassard D, Clavier F, Bry P, Verdier F.

J Antimicrob Chemother. 1994 Nov;34(5):803-8.

PMID:
7706177
44.

Insulin secretion in rats with chronic nitric oxide synthase blockade.

Pueyo ME, Gonzalez W, Pussard E, Arnal JF.

Diabetologia. 1994 Sep;37(9):879-84.

PMID:
7528695
45.

Noninvasive assessment of regional arteriolar and arterial dilating properties of lisinopril in healthy volunteers.

Bellissant E, Thuillez C, Richer C, Pussard E, Giudicelli JF.

J Cardiovasc Pharmacol. 1994 Sep;24(3):500-8.

PMID:
7528307
46.

Heterogeneous regional vascular responses to simulated transient hypovolemia in man.

Edouard AR, Degrémont AC, Duranteau J, Pussard E, Berdeaux A, Samii K.

Intensive Care Med. 1994 Jul;20(6):414-20.

PMID:
7798445
47.

Antimalarial 4-aminoquinolines: mode of action and pharmacokinetics.

Pussard E, Verdier F.

Fundam Clin Pharmacol. 1994;8(1):1-17. Review.

PMID:
8181791
48.

[Relationships between plasma concentrations of endothelin and the severity of liver cirrhosis].

Hartleb M, Kirstetter P, Moreau R, Soupison T, Pussard E, Hadengue A, Sogni P, Gaudin C, Lebrec D.

Gastroenterol Clin Biol. 1994;18(5):407-12. Review. French.

PMID:
7813855
49.

Efficacy of intramuscular amopyroquin for treatment of Plasmodium falciparum malaria in the Gabon Republic.

Gaudebout C, Pussard E, Clavier F, Gueret D, Le Bras J, Brandicourt O, Verdier F.

Antimicrob Agents Chemother. 1993 May;37(5):970-4.

50.

Cardiopulmonary and carotid baroreflex control of splanchnic and forearm circulations.

Escourrou P, Raffestin B, Papelier Y, Pussard E, Rowell LB.

Am J Physiol. 1993 Mar;264(3 Pt 2):H777-82.

PMID:
8456981

Supplemental Content

Loading ...
Support Center